🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣The Parkinson’s Progression Markers Initiative (#PPMI) work recently demonstrated how αSyn-SAA could be a novel tool for precision medicine approaches, earlier intervention, and improved clinical trial design for #PD. ⬇️ (1/2) pulse.ly/0436dr3ndh

Hot off the press! Approaches to studying antigen-specific T cells and their TCR repertoire. frontiersin.org/articles/10.33… A pleasure to work with these talented scientists! #WomenInSTEM La Jolla Institute Sudha @sloanlewis kendall Leila Chihab

Such a pleasure visiting collaborators in Kenya.

Imagine if subunit vaccines should be given only once! Check out our latest paper describing how BCG and our new TB vaccine candidate synergize to be efficacious after a single dose compared to traditional prime-boost! Thanks to all for the hard work! rdcu.be/dbLPR

Promising TB vaccine candidate! Excited to have played a small part in this study.

Great job, Sudha

I'm also looking forward to this workshop 👇! See you there? La Jolla Institute

Researchers find new links between #Tcell exhaustion and #Alzheimers — with contributions from LJI's Alessandro Sette and Cecilia Lindestam Arlehamn nature.com/articles/s4159… #Immunology #Neuroinflammation #Aging #Neuroscience #ImmuneCells Scientific Reports

Our new pre-print is online! biorxiv.org/content/10.110… T cells from patients with PD recognize PINK1 as an autoantigen La Jolla Institute Alessandro Sette

Sunday is #WorldTBDay 2024. The End TB Alliance have some excellent social media resources.

#WorldTBDay2024 and the start of the #TBKeystone looking forward to this conference! La Jolla Institute Sudha

New #tuberculosis research review from LJI Research Assistant Professor Cecilia Lindestam Arlehamn (Cecilia Lindestam Arlehamn) and LJI colleagues: "From antigens to immune responses: Shaping the future of TB detection and prevention." pubmed.ncbi.nlm.nih.gov/38417617/ #GlobalHealth #TB #VaccineResearch

Join us in Stockholm in September! mycobact2024.se

A fantastic meeting as always! La Jolla Institute Tom Riffelmacher

Join us in Stockholm 4-6th of September for Mycobact2024 Abstract deadline on June 21st! mycobact2024.se/abstractsubmis…